Intrexon Corporation
31 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 6 name spellings.
Recorded as renamed to Precigen, Inc. (2020)
9
Ending by 2030
May 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 11, 2027The maintenance fee for Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex (US 9,102,648) comes due Feb 11, 2027. Unpaid by Aug 11, 2027, it lapses early.
- 1 fee due Apr 20, 2027The maintenance fee for Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene Expression System (US 9,163,256) comes due Apr 20, 2027. Unpaid by Oct 20, 2027, it lapses early.
- 2 fees due Jun 10, 2027
- 1 fee due Sep 10, 2027The maintenance fee for Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising the Vectors, and Uses Thereof (US 10,584,351) comes due Sep 10, 2027. Unpaid by Mar 10, 2028, it lapses early.
- 1 fee due Oct 28, 2027The maintenance fee for Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex (US 10,633,361) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,034,650 | Site-specific serine recombinases and methods of their use In force · High confidence | In force | High confidence | |
| US 7,705,122 | Mtor Ligands and Polynucleotides Encoding Mtor Ligands In force · High confidence | In force | High confidence | |
| US 8,884,060 | Process of Preparing Chiral Diacylhydrazine Ligands In force · Medium confidence | In force | Medium confidence | |
| US 9,675,642 | Engineered Dendritic Cells and Uses for the Treatment of Cancer In force · Medium confidence | In force | Medium confidence | |
| US 9,163,256 | Mutant Receptors and Their Use in a Nuclear Receptor-Based Inducible Gene Expression System In force · Medium confidence | In force | Medium confidence | |
| US 10,633,361 | Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex In force · Medium confidence | In force | Medium confidence | |
| US D742,785 | Container In force · From the USPTO record | In force | From the USPTO record | |
| US 8,114,024 | Seal for a rotating shaft In force · From the USPTO record | In force | From the USPTO record | |
| US 9,102,648 | Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex In force · Medium confidence | In force | Medium confidence | |
| US 10,584,351 | Vectors Conditionally Expressing Therapeutic Proteins, Host Cells Comprising the Vectors, and Uses Thereof In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 18: 31 patents in force now held by others · 88 lapsed for an unpaid fee · 48 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 7 abandoned · 46 no status recorded